Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kollender Richard S, Chief Financial Officer. Director active across 3 companies, notably Strongbridge Biopharma plc. Aggregated, 11 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €46k. History available since 17 May 2021. The latest transaction was filed on 24 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kollender Richard S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11,392 shares@ US$2.2812.6% of flowOrdinary SharesSEC:0001179110-21-005554:0
11 of 11 declarations
About Kollender Richard S
Richard S. Kollender is President and CFO of Strongbridge Biopharma plc and RAPID MICRO BIOSYSTEMS, INC. In these roles, he is responsible for financial management and strategic leadership of both companies. Richard plays a key role in developing financial strategies that support growth and profitability.